BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 19628194)

  • 1. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
    Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
    JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
    Hong MK; Park DW; Lee CW; Lee SW; Kim YH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2009 Jul; 2(7):679-88. PubMed ID: 19628193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
    Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Hibi K; Sozu T; Terashima M; Michishita I;
    Coron Artery Dis; 2013 Sep; 24(6):481-6. PubMed ID: 23751736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis.
    Clementi F; Di Luozzo M; Mango R; Luciani G; Trivisonno A; Pizzuto F; Martuscelli E; Mehta JL; Romeo F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):231-7. PubMed ID: 19262209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy.
    Kwon O; Kang SJ; Kang SH; Lee PH; Yun SC; Ahn JM; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Park SW; Park SJ
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28679524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.
    Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A
    Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
    Samady H; McDaniel MC
    JACC Cardiovasc Interv; 2009 Jul; 2(7):697-700. PubMed ID: 19628195
    [No Abstract]   [Full Text] [Related]  

  • 11. Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I;
    Nephrology (Carlton); 2012 Sep; 17(7):628-35. PubMed ID: 22708952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.
    Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I
    Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on optical coherence tomographic coronary findings of fluvastatin alone versus fluvastatin + ezetimibe.
    Habara M; Nasu K; Terashima M; Ko E; Yokota D; Ito T; Kurita T; Teramoto T; Kimura M; Kinoshita Y; Tsuchikane E; Asakura Y; Matsubara T; Suzuki T
    Am J Cardiol; 2014 Feb; 113(4):580-7. PubMed ID: 24388622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of coronary plaque evaluation between multislice computed tomography and intravascular ultrasound radiofrequency data analysis.
    Pundziute G; Schuijf JD; Jukema JW; Decramer I; Sarno G; Vanhoenacker PK; Reiber JH; Schalij MJ; Wijns W; Bax JJ
    JACC Cardiovasc Interv; 2008 Apr; 1(2):176-82. PubMed ID: 19463297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Statin Therapy on Coronary Plaque Composition Using Virtual Histology Intravascular Ultrasound: A Meta-Analysis.
    Zheng G; Li Y; Huang H; Wang J; Hirayama A; Lin J
    PLoS One; 2015; 10(7):e0133433. PubMed ID: 26225936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
    J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
    Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
    JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Effects of Intensive Lipid-Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound.
    Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2016 Sep; 57(5):1087-94. PubMed ID: 27401638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.